Drug Neuroscience

Abilify

Payments companies reported to CMS as associated with Abilify. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$5,735associated payments (2023-2025)
155clinicians with associated payments
2companies reporting

By year

2023 $4,027
2024 $877
2025 $832

Payments reported as associated with Abilify, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $1,263
Family Medicine $999
Internal Medicine $991
Interventional Cardiology $818
Hematology & Oncology $404
Clinical Cardiac Electrophysiology $369

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Abilify

These are the largest totals companies reported as associated with Abilify. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Christine Theard Laguna Niguel, CA Cardiovascular Disease $334.72
Milan Patel Laguna Hills, CA Interventional Cardiology $323.18
Carlos Ayon Martinez Temecula, CA Family Medicine $245.36
Hohai Van Laguna Hills, CA Interventional Cardiology $212.04
Paul Drury Laguna Hills, CA Clinical Cardiac Electrophysiology $212.04
Charles Parise Laguna Beach, CA Cardiovascular Disease $200.50
Jeffrey Chung Murrieta, CA Cardiovascular Disease $150.64
Cheng-Han Chen Laguna Hills, CA Interventional Cardiology $122.68
George Konugres Laguna Hills, CA Cardiovascular Disease $122.68
Greg Brown San Clemente, CA Internal Medicine $122.68

Prescribed Abilify?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.